Sarepta Stock Catapults Higher After Eking Out A Narrow Win In Its Gene Therapy Battle
Shares of SRPT stock launched higher Monday after Food and Drug Administration advisors voted late Friday in support of a highly anticipated gene therapy from Sarepta Therapeutics (SRPT). Sarepta is testing the gene therapy in […]